Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2360 Target Snapshot

Hypoxanthine-guanine phosphoribosyltransferase · SINGLE PROTEIN · Homo sapiens

299Compounds
65Assays
0Approved Drugs
247.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P00492. Use UniProt P00492 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P00492 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Hypoxanthine-guanine phosphoribosyltransferase as ChEMBL target CHEMBL2360, mapped to UniProt P00492. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Hypoxanthine-guanine phosphoribosyltransferase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2360
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P00492
Hypoxanthine-guanine phosphoribosyltransferase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Hypoxanthine-guanine phosphoribosyltransferase is the right protein anchor across sources, using UniProt P00492 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelHypoxanthine-guanine phosphoribosyltransferase
UniProt AccessionP00492
Component TypeProtein
Sequence Length218 aa

Hypoxanthine-guanine phosphoribosyltransferase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Hypoxanthine-guanine phosphoribosyltransferase, mapped to UniProt P00492. Sequence length is 218 aa.

Mapped IDP00492
Review nameHypoxanthine-guanine phosphoribosyltransferase
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC503.0
KI243.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4282830 9.0 Ki 1.0 Preclinical
CHEMBL5184028 8.89 Ki 1.3 Preclinical
CHEMBL1233663 8.74 Ki 1.8 Preclinical
CHEMBL4290716 8.52 Ki 3.0 Preclinical
CHEMBL5573402 8.52 Ki 3.0 Preclinical
CHEMBL1233603 8.34 Ki 4.6 Preclinical
CHEMBL4086362 8.22 Ki 6.0 Preclinical
CHEMBL5207635 8.22 Ki 6.0 Preclinical
CHEMBL4277753 8.1 Ki 8.0 Preclinical
CHEMBL4285691 8.1 Ki 8.0 Preclinical
Distribution

pChEMBL Value Distribution

42
5.0
24
5.5
31
6.0
13
6.5
21
7.0
8
7.5
7
8.0
6
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

67
Total Assays
169
Tested Compounds
3
Assay Types
Binding — 52 assays, 169 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 48 160 6.0
assay format 3 4 6.0
cell-based format 1 5 5.8
Functional — 12 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 12 0
ADME — 3 assays, 9 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 3 9 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine